Skip to Main Content

Archives

05.06.21

Lessons from One of the World’s Most Successful, Yet Unusual, COVID-19 Vaccination Campaigns

By O’Neill Institute

This expert column was written by Kashish Aneja and Nishtha Arora. As of April 8, 2021, the Ministry of Health of the Royal Kingdom of Bhutan reported having administered the first doses of COVID-19 vaccines to almost 93% of its eligible adult population. 85% of its eligible adult population was vaccinated within the first week […]

Tags:

05.05.21

Statement from Matthew Kavanagh on U.S. Support for TRIPS Waiver

By Cynthia Sun

  May 5, 2021 Please see below for a statement from the O’Neill Institute’s Director for Global Health Policy and Politics Matthew Kavanagh: Today at the World Trade Organization (WTO), U.S. Ambassador Katherine Tai released a statement announcing the Biden administration’s support of the TRIPS waiver of patents on COVID-19 vaccines. U.S. support of the […]

Tags:

04.15.21

The Promise and Peril of Vaccine Passports

By O’Neill Institute

This expert column was written by Anastasia Vernikou and Katherine Ginsbach. As the rollout of COVID-19 vaccines has progressed, countries have begun to look for ways to lift restrictive public health measures, like lockdowns. This has amplified the discussion around the effectiveness and potential challenges of vaccine certificates, or passports. Showing proof of vaccination record […]

Tags:

03.29.21

Statement from Matthew Kavanagh on WHO’s COVID Origins Report

By Cynthia Sun

  March 29, 2021 Please see below for a statement from the O’Neill Institute’s Director for Global Health Policy and Politics Matthew Kavanagh: The Associated Press reports that a panel of scientists tasked by the World Health Organization to research the origins of the COVID-19 pandemic find the virus was most likely transmitted from animals to humans, […]

Tags:

03.09.21

Better Masks Offer Better Protection Against COVID-19 Variants. Governments Should Act Quickly.

By O’Neill Institute

This expert column was written by Katherine Ginsbach and Anastasia Vernikou.  SARS-CoV-2 is mutating. More than a year into the COVID-19 epidemic, virus mutations are increasing transmission rates, compounding the opportunities to transform further. Given the ever-expanding risk to population health, governments must continuously monitor the efficacy of current public health regulations, making needed updates […]

Tags:

01.14.21

India Must Have Vaccine Transparency for the World’s Largest Immunization Program to Succeed

By O’Neill Institute

This expert column was written by Kashish Aneja.  On January 16, India is set to launch the world’s largest national immunization programme with two of its ‘made in India’ vaccines. India sits at the center of the COVID-19 response, not just because it has the second-highest number of global cases, or only due to its […]

Tags:

11.30.20

HIV Policies In Most Countries Are Not Aligned With International Standards, Undermining Progress Against AIDS, New Report Shows

By Cynthia Sun

FOR IMMEDIATE RELEASE  November 30, 2020 Washington, DC — With the global AIDS response set to miss 2020 targets and COVID-19 threatening to derail progress, a new report today shows that many countries have not adopted key policies needed to take advantage of scientific breakthroughs in HIV. The science of HIV has never been better, […]

Tags:

10.20.20

Leading the COVID-19 Vaccination Response: Lessons Learned from the Smallpox Eradication Campaign

By O’Neill Institute

This expert column was written by Adi Radhakrishnan.  With more than 40 million known cases worldwide, and many countries already experiencing a second surge, the global recovery from COVID-19 still appears far away. Experts recently forecast that that the full course of the pandemic will likely run for two years and will only subside if […]

Tags:

09.29.20

New HIV Policy Lab uses law and policy data in the HIV response

By Cynthia Sun

FOR IMMEDIATE RELEASE 29 September 2020 WASHINGTON/GENEVA—Despite decades of scientific advances in the HIV response, progress remains uneven, with some countries rapidly reducing AIDS-related deaths and new HIV infections and others seeing increasing epidemics. Laws and policies are driving a significant part of that divergence.  Launched today, the HIV Policy Lab is a unique initiative to gather and monitor […]

Tags:

The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.